Journal article
Clozapine users in Australia: their characteristics and experiences of care based on data from the 2010 National Survey of High Impact Psychosis
DJ Siskind, M Harris, A Phillipou, VA Morgan, A Waterreus, C Galletly, VJ Carr, C Harvey, D Castle
Epidemiology and Psychiatric Sciences | Cambridge University | Published : 2017
Abstract
Copyright © Cambridge University Press 2016Aims.: Clozapine is the most effective medication for treatment refractory schizophrenia. However, descriptions of the mental health and comorbidity profile and care experiences of people on clozapine in routine clinical settings are scarce. Using data from the 2010 Australian Survey of High Impact Psychosis, we aimed to examine the proportion of people using clozapine, and to compare clozapine users with other antipsychotic users on demographic, mental health, adverse drug reaction, polypharmacy and treatment satisfaction variables. Methods.: Data describing 1049 people with a diagnosis of schizophrenia or schizoaffective disorder, who reported tak..
View full abstractGrants
Awarded by National Health and Medical Research Council, Early Career Fellowship
Funding Acknowledgements
The 2010 Australian National Survey of High Impact Psychosis was funded by the Australian Government Department of Health and Ageing. D J Siskind is supported by a National Health and Medical Research Council, Early Career Fellowship 2016-2019 (APP1111136).